References
- Mäkitie A, Cange HH, Hammarstedt-Nordenvall L, et al. Head and neck cancer management in the Nordic countries: an effort to harmonize treatment. Eur Arch Otorhinolaryngol. 2017;274:2363–2365.
- Jin H, Pinheiro PS, Xu J, et al. Cancer incidence among Asian American populations in the United States, 2009–2011. Int J Cancer. 2016;138:2136–2145.
- Engholm G, Ferlay J, Christensen N, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic Countries, version 7.3 (08.07.2016). Association of the Nordic cancer registries. Danish Cancer Society. Available from: http://www.ancr.nu
- Lee AW, Ma BB, Ng WT, et al. Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol. 2015;33:3356–3364.
- Blanchard P, Lee A, Marguet S, MAC-NPC Collaborative Group, et al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol. 2015;16:645–655.
- Lee AW, Ngan RK, Tung SY, et al. Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma. Cancer. 2015;121:1328–1338.
- Zhang MX, Li J, Shen GP, et al. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up. Eur J Cancer. 2015;51:2587–2595.
- Lewis GD, Holliday EB, Kocak-Uzel E, et al. Intensity-modulated proton therapy for nasopharyngeal carcinoma: decreased radiation dose to normal structures and encouraging clinical outcomes. Head Neck. 2016;38(Suppl 1):E1886–E1895.
- Tsang RK, To VS, Ho AC, et al. Early results of robotic assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma. Head Neck. 2015;37:788–793.
- Chan KCA, Woo JKS, King A, et al. Analysis of plasma Epstein–Barr Virus DNA to screen for nasopharyngeal cancer. N Engl J Med. 2017;377:513–522.
- Simo R, Robinson M, Lei M, et al. Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130:S97–S103.
- Gooi Z, Richmon J, Agrawal N, et al. AHNS series – do you know your guidelines? Principles of treatment for nasopharyngeal cancer: a review of the National Comprehensive Cancer Network guidelines. Head Neck. 2017;39:201–205.